Tyler Dylan-hyde - Net Worth and Insider Trading
Tyler Dylan-hyde Net Worth
The estimated net worth of Tyler Dylan-hyde is at least $1 Million dollars as of 2024-04-24. Tyler Dylan-hyde is the Chief Legal Officer of CRISPR Therapeutics AG and owns about 25,204 shares of CRISPR Therapeutics AG (CRSP) stock worth over $1 Million. Details can be seen in Tyler Dylan-hyde's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tyler Dylan-hyde has not made any transactions after 2018-01-16 and currently still holds the listed stock(s).
Transaction Summary of Tyler Dylan-hyde
Tyler Dylan-hyde Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tyler Dylan-hyde owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .
Click here to see the complete history of Tyler Dylan-hyde’s form 4 insider trades.
Insider Ownership Summary of Tyler Dylan-hyde
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2018-01-16 | Chief Legal Officer |
Tyler Dylan-hyde Latest Holdings Summary
Tyler Dylan-hyde currently owns a total of 1 stock. Tyler Dylan-hyde owns 25,204 shares of CRISPR Therapeutics AG (CRSP) as of January 16, 2018, with a value of $1 Million.
Latest Holdings of Tyler Dylan-hyde
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2018-01-16 | 25,204 | 55.76 | 1,405,375 |
Holding Weightings of Tyler Dylan-hyde
Tyler Dylan-hyde Form 4 Trading Tracker
According to the SEC Form 4 filings, Tyler Dylan-hyde has made a total of 0 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years. The most-recent trade in CRISPR Therapeutics AG is the sale of 66,000 shares on January 16, 2018, which brought Tyler Dylan-hyde around $2 Million.
Insider Trading History of Tyler Dylan-hyde
- 1
Tyler Dylan-hyde Trading Performance
Tyler Dylan-hyde Ownership Network
Ownership Network List of Tyler Dylan-hyde
Ownership Network Relation of Tyler Dylan-hyde
Tyler Dylan-hyde Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
Tyler Dylan-hyde is the Chief Legal Officer of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Business Officer Samarth Kulkarni , Chief Financial Officer Raju Prasad , and General Counsel and Secretary James R. Kasinger .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, Tyler Dylan-hyde made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 350,337 shares made by Samarth Kulkarni , a net sale of 5,860 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .
In summary, during the past 3 months, insiders sold 139,721 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 139,721 shares. During the past 18 months, 359,721 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 359,721 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
Tyler Dylan-hyde Mailing Address
Above is the net worth, insider trading, and ownership report for Tyler Dylan-hyde. You might contact Tyler Dylan-hyde via mailing address: C/o Crispr Therapeutics Ag, 200 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
